CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 12 enrolled
Drug / intervention
Mesenchymal stromal cell therapybiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01909154
NCT01909154Phase 1Completed
CompareCT.gov

Phase I Pilot Study to Evaluate the Security of Local Administration of Autologous Stem Cells Obtained From the Bone Marrow Stroma, in Traumatic Injuries of the Spinal Cord

Puerta de Hierro University Hospital·interventional·Posted Jul 26, 2013·Updated Mar 29, 2019

In Brief

A Phase 1 clinical trial evaluating Mesenchymal stromal cell therapy for Spinal Cord Injury. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The purpose of this study is to confirm the security, and detect the effect of the local administration in damaged nervous tissue, of autologous bone marrow stromal cells.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpinal Cord Injury
CountriesSpain
Collaborators--

Timeline

Phase 1CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 26, 2013
Enrollment StartMar 1, 2013
Primary CompletionApr 1, 2014
Study CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 12.9 years ago

Interventions

Mesenchymal stromal cell therapybiological

Stem cells administration locally